Clinical Trials Directory

Trials / Completed

CompletedNCT01937494

Bronchial Hyperreactivity During Histamine Passive Exposure

Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Centre Hospitalier Universitaire Saint Pierre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bronchial hyperresponsiveness consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma (metacholine or histamine).Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction even if they suffer from BHR.The purpose of the study is to determine if patients with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are developing a bronchoconstriction, when placed in the same conditions that the technicians performing these tests.

Detailed description

Bronchial hyperresponsiveness (BHR) consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma.BHR is also present in other diseases such as allergic rhinitis, Chronic Obstructive pulmonary disease,heart failure.. Thes test is performed with metacholine or histamine with spirometric documented response to incremental doses.Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction if they suffer from BHR. The purpose of the study is to determine if patients, newly diagnosed with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are reacting to histamine when placed in the same conditions that the technicians performing these tests.

Conditions

Interventions

TypeNameDescription
DRUGhistamine-benzylic alcohol (magistral preparation)passive exposure to histamine during a bronchial hyperresponsiveness challenge

Timeline

Start date
2013-05-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2013-09-09
Last updated
2015-02-23

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01937494. Inclusion in this directory is not an endorsement.